Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mariella Trovati

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Journal of the American Society of Nephrology : JASN|December 20, 2003
Optimization of hypolipidemic and antiplatelet treatment in the diabetic patient with renal diseaseMariella Trovati, Franco Cavalot
Cardiovascular & Hematological Agents in Medicinal Chemistry|April 14, 2006
Pathophysiology of platelet resistance to anti-aggregating agents in insulin resistance and type 2 diabetes: implications for anti-aggregating therapyGiovanni Anfossi, Mariella Trovati
Journal of Diabetes and Its Complications|March 2, 2002
Influence of insulin and of insulin resistance on platelet and vascular smooth muscle cell functionMariella Trovati, Giovanni Anfossi
Current Diabetes Reports|March 20, 2003
Mechanisms involved in platelet hyperactivation and platelet-endothelium interrelationships in diabetes mellitusMariella Trovati, Giovanni Anfossi
Current Vascular Pharmacology|October 16, 2008
Resistance to aspirin and thienopyridines in diabetes mellitus and metabolic syndromeGiovanni Anfossi, Isabella Russo, Mariella Trovati
Current Diabetes Reviews|January 29, 2008
Platelet resistance to the anti-aggregating agents in the insulin resistant statesGiovanni Anfossi, Isabella Russo, Mariella Trovati
Cardiovascular & Hematological Disorders Drug Targets|January 29, 2008
Relevance of the vascular effects of insulin in the rationale of its therapeutical useGiovanni Anfossi, Isabella Russo, Gabriella Doronzo, et al.
Current Vascular Pharmacology|June 3, 2009
The cardiovascular effects of metformin: further reasons to consider an old drug as a cornerstone in the therapy of type 2 diabetes mellitusGiovanni Anfossi, Isabella Russo, Katia Bonomo, et al.
Archives of Physiology and Biochemistry|August 19, 2009
Contribution of insulin resistance to vascular dysfunctionGiovanni Anfossi, Isabella Russo, Gabriella Doronzo, et al.
Thrombosis and Haemostasis|January 18, 2006
Homocysteine rapidly increases matrix metalloproteinase-2 expression and activity in cultured human vascular smooth muscle cells. Role of phosphatidyl inositol 3-kinase and mitogen activated protein kinase pathwaysGabriella Doronzo, Isabella Russo, Luigi Mattiello, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Journal of the American Society of Nephrology : JASN|December 20, 2003
Optimization of hypolipidemic and antiplatelet treatment in the diabetic patient with renal diseaseMariella Trovati, Franco Cavalot
Cardiovascular & Hematological Agents in Medicinal Chemistry|April 14, 2006
Pathophysiology of platelet resistance to anti-aggregating agents in insulin resistance and type 2 diabetes: implications for anti-aggregating therapyGiovanni Anfossi, Mariella Trovati
Journal of Diabetes and Its Complications|March 2, 2002
Influence of insulin and of insulin resistance on platelet and vascular smooth muscle cell functionMariella Trovati, Giovanni Anfossi
Current Diabetes Reports|March 20, 2003
Mechanisms involved in platelet hyperactivation and platelet-endothelium interrelationships in diabetes mellitusMariella Trovati, Giovanni Anfossi
Current Vascular Pharmacology|October 16, 2008
Resistance to aspirin and thienopyridines in diabetes mellitus and metabolic syndromeGiovanni Anfossi, Isabella Russo, Mariella Trovati
Current Diabetes Reviews|January 29, 2008
Platelet resistance to the anti-aggregating agents in the insulin resistant statesGiovanni Anfossi, Isabella Russo, Mariella Trovati
Cardiovascular & Hematological Disorders Drug Targets|January 29, 2008
Relevance of the vascular effects of insulin in the rationale of its therapeutical useGiovanni Anfossi, Isabella Russo, Gabriella Doronzo, et al.
Current Vascular Pharmacology|June 3, 2009
The cardiovascular effects of metformin: further reasons to consider an old drug as a cornerstone in the therapy of type 2 diabetes mellitusGiovanni Anfossi, Isabella Russo, Katia Bonomo, et al.
Archives of Physiology and Biochemistry|August 19, 2009
Contribution of insulin resistance to vascular dysfunctionGiovanni Anfossi, Isabella Russo, Gabriella Doronzo, et al.
Thrombosis and Haemostasis|January 18, 2006
Homocysteine rapidly increases matrix metalloproteinase-2 expression and activity in cultured human vascular smooth muscle cells. Role of phosphatidyl inositol 3-kinase and mitogen activated protein kinase pathwaysGabriella Doronzo, Isabella Russo, Luigi Mattiello, et al.
Pageof 4